. Data characterizing the GSH--MDI reac<on products generated in vitro. Panels a & b show A 210 and A 245 of different frac<ons of GSH--MDI reac<on products separated by reverse phase HPLC as described. Panels c, d, and e show LC--MS data for different purified frac<ons (labeled I, II, III), which correspond to the structures shown on the right, as previously described, 1--3 or an asymmetric (S,N'--linked) bis(GSH)--MDI also shown, which could theore<cally form via direct reac<vity between GSH and MDI, or via inter--or intra--molecular rearrangement of (S,S'--linked) bis(GSH)--MDI. Fixed modifications: Carbamidomethyl (C),iTRAQ4plex (N-term),iTRAQ4plex (K) (apply to specified residues or termini only) Supplemental Figure S2 . MS/MS data defining unique modification of murine albumin K 414 . Data from iTRAQ experiments were queried for the expected 614 atomic mass unit modification due to GSH-MDI addition and carbamidomethylation (during sample workup). Raw data from the MASCOT search engine showing b-and y-ions confirming amino acid sequence, and modification on the K residue. Supplemental Table S1 . Supplemental Table S2 . Identification of GSH -MDI modified albumin peptide in samples from GSH-MDI exposed mice (114, 115) not control mice exposed to MDI -m (116, 117). Differences in amount of different ions with masses that match peptides of mouse albumin, or MDI modified mouse albumin from GSH-MDI exposed mice (e.g. 114 and 115) vs. controls (116 and 117). Shown are the Score, Expectation, Sequence and Charge data (same as Table S1 ), paired with quantitation of the respective amounts of ion with 114, 115, 116, or 117 labels, and their relative ratios as labeled. The ion mass corresponding to the GSH-MDI modified murine albumin peptide of interested is highlighted. 
